| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $157.1M | -25.1% |
| R&D Expense | $148.7M | -7.6% |
| SG&A Expense | $145.4M | +1.1% |
| Operating Income | -$142.2M | -44.7% |
| Interest Expense | $25.0M | -4.0% |
| Pre-tax Income | -$164.9M | -33.2% |
| Income Tax | $369K | +37.7% |
| Net Income | -$165.3M | -33.2% |
| EPS (Basic) | -$2.02 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.2M | -29.0% |
| Accounts Receivable | $47.1M | +109.3% |
| Inventory | $4.2M | +2.9% |
| Current Assets | $350.2M | +27.1% |
| Total Assets | $358.2M | +17.3% |
| Current Liabilities | $65.9M | -10.6% |
| Total Liabilities | $374.8M | -2.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.6M | -39.6% |
| Capital Expenditures | $118K | -44.3% |
| Investing Cash Flow | -$104.3M | -173.5% |
| Financing Cash Flow | $193.7M | +163.1% |
| Free Cash Flow | -$149.7M | -39.5% |
| -22.4% |
| EPS (Diluted) | -$2.02 | -22.4% |
| Stockholders' Equity |
| -$16.7M |
| +79.1% |